Corcept Therapeutics
CORT
CORT
183 hedge funds and large institutions have $962M invested in Corcept Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $1.03B → $962M (-$65.1M)
12% less funds holding
Funds holding: 208 → 183 (-25)
53% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 38
Holders
183
Holding in Top 10
1
Calls
$5.21M
Puts
$3.27M
Top Buyers
| 1 | +$9.58M | |
| 2 | +$6.18M | |
| 3 | +$5.94M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$5.83M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$5.2M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.64M | |
| 3 | -$4.74M | |
| 4 |
Goldman Sachs
New York
|
-$3.75M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.69M |